This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (121)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Movement Disorders  • Parkinson Disease/ Parkinsonian Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Chris Zarow, PhD; Scott A. Lyness, MA; James A. Mortimer, PhD; Helena C. Chui, MD

Arch Neurol. 2003;60:337-341.

Context  Alzheimer disease (AD) and Parkinson disease (PD) are associated with neuronal degeneration in major subcortical nuclei, but few studies have examined the neuronal degeneration in these nuclei concurrently.

Objective  To identify clinical and pathological correlates of neuronal loss in the nucleus basalis (NB), locus coeruleus (LC), and substantia nigra pars compacta (SN) in AD and PD.

Design  The study sample comprised 86 cases with pathologically confirmed AD, 19 cases with PD, and 13 healthy elderly control subjects. The number of nucleolated neurons was counted in representative sections of the NB, LC, and SN. Effect sizes (ES) were computed to determine the standardized difference in cell counts relative to healthy controls.

Results  Cases of AD showed the greatest neuronal loss in the LC (ES = 3.16) followed by the NB (ES = 1.10), but variable loss in the SN (ES = 0.16). Cases of PD also showed the greatest neuronal loss in the LC (ES = 6.47), followed by the SN (ES = 2.58) and the NB (ES = 0.85). Significant correlations were found between the number of neurons in the NB and LC in PD (r = 0.54, P<.05), as well as AD (r = 0.24, P<.05). The duration of illness correlated with greater neuronal loss in the LC and NB in AD, and greater neuronal loss in the SN in PD.

Conclusions  For both AD and PD the greatest neuronal loss was found in the LC. In AD, neuronal loss was most severe and best correlated with the duration of illness in the LC, rather than in NB as traditionally expected. Correlations between neuronal loss in the LC and NB (but not SN) in both PD and AD suggest that the former 2 nuclei may share common pathogenetic susceptibilities. Given the prominent loss of neurons in the LC, detection and treatment of noradrenergic deficiencies warrant attention in both AD and PD.

From the Department of Neurology, University of Southern California, Los Angeles, and Rancho Los Amigos National Rehabilitation Center, Downey, Calif (Drs Zarow and Chui and Mr Lyness); and the University of South Florida Institute on Aging, Tampa (Dr Mortimer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Time to Focus on the Locus
David Rye and Mahlon R. DeLong
Arch Neurol. 2003;60(3):320.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pain sensitivity and descending inhibition of pain in Parkinson's disease
Mylius et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:24-28.
ABSTRACT | FULL TEXT  

Marked Hyperphagia Associated With Total Loss of Satiety in Alzheimer's Disease
Bhagavati
J. Neuropsychiatry Clin. Neurosi. 2008;20:248-249.
FULL TEXT  

Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: A TMS study
Baumer et al.
Neurology 2007;69:1976-1981.
ABSTRACT | FULL TEXT  

Selective Loss of Catecholaminergic Wake Active Neurons in a Murine Sleep Apnea Model
Zhu et al.
J. Neurosci. 2007;27:10060-10071.
ABSTRACT | FULL TEXT  

Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice
Rommelfanger et al.
Proc. Natl. Acad. Sci. USA 2007;104:13804-13809.
ABSTRACT | FULL TEXT  

Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia
Bohnen et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:641-643.
ABSTRACT | FULL TEXT  

Inverse Relationship Between Brain Noradrenaline Level and Dopamine Loss in Parkinson Disease: A Possible Neuroprotective Role for Noradrenaline
Tong et al.
Arch Neurol 2006;63:1724-1728.
ABSTRACT | FULL TEXT  

The Phenotypic Differentiation of Locus Ceruleus Noradrenergic Neurons Mediated by Brain-Derived Neurotrophic Factor Is Enhanced by Corticotropin Releasing Factor through the Activation of a cAMP-Dependent Signaling Pathway
Traver et al.
Mol. Pharmacol. 2006;70:30-40.
ABSTRACT | FULL TEXT  

Proteasomal dysfunction in sporadic Parkinson's disease
McNaught et al.
Neurology 2006;66:S37-S49.
ABSTRACT | FULL TEXT  

Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice
Heneka et al.
J. Neurosci. 2006;26:1343-1354.
ABSTRACT | FULL TEXT  

Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models
Yang et al.
J. Neurosci. 2006;26:775-784.
ABSTRACT | FULL TEXT  

Progression of motor impairment and disability in Parkinson disease: A population-based study
Alves et al.
Neurology 2005;65:1436-1441.
ABSTRACT | FULL TEXT  

Bcl-x Is Required for Proper Development of the Mouse Substantia Nigra
Savitt et al.
J. Neurosci. 2005;25:6721-6728.
ABSTRACT | FULL TEXT  

The Neurotransmitter Noradrenaline Rescues Septal Cholinergic Neurons in Culture from Degeneration Caused by Low-Level Oxidative Stress
Traver et al.
Mol. Pharmacol. 2005;67:1882-1891.
ABSTRACT | FULL TEXT  

Clinical assessment of nocturnal disability in Parkinson's disease: The Parkinson's Disease Sleep Scale
Chaudhuri and Martinez-Martin
Neurology 2004;63:S17-S20.
FULL TEXT  

Loss of locus coeruleus neurons and reduced startle in parkin null mice
von Coelln et al.
Proc. Natl. Acad. Sci. USA 2004;101:10744-10749.
ABSTRACT | FULL TEXT  

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Zecca et al.
Proc. Natl. Acad. Sci. USA 2004;101:9843-9848.
ABSTRACT | FULL TEXT  

Pain in Parkinson disease
Buzas and Max
Neurology 2004;62:2156-2157.
FULL TEXT  

Noradrenergic Activity is Associated with Response to Pindolol in Aggressive Alzheimer's Disease Patients
Herrmann et al.
J Psychopharmacol 2004;18:215-220.
ABSTRACT  

The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam
Learn. Mem. 2004;11:43-49.
ABSTRACT | FULL TEXT  

Focus on the Locus
Burke
Arch Neurol 2003;60:1493-1493.
FULL TEXT  

Time to Focus on the Locus
Rye and DeLong
Arch Neurol 2003;60:320-320.
FULL TEXT